TGK Stock Overview
A healthcare solutions company, provides diagnostic products, reagents, and services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Precipio, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.32 |
| 52 Week High | US$17.78 |
| 52 Week Low | US$5.08 |
| Beta | 1.77 |
| 1 Month Change | 0% |
| 3 Month Change | -3.62% |
| 1 Year Change | -49.97% |
| 3 Year Change | -83.88% |
| 5 Year Change | n/a |
| Change since IPO | -95.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| TGK | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -2.0% |
| 1Y | -50.0% | 15.8% | 6.8% |
Return vs Industry: TGK underperformed the German Healthcare industry which returned 12.9% over the past year.
Return vs Market: TGK underperformed the German Market which returned 9.5% over the past year.
Price Volatility
| TGK volatility | |
|---|---|
| TGK Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TGK has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TGK's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 55 | Ilan Danieli | www.precipiodx.com |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests.
Precipio, Inc. Fundamentals Summary
| TGK fundamental statistics | |
|---|---|
| Market cap | €8.47m |
| Earnings (TTM) | -€8.31m |
| Revenue (TTM) | €12.15m |
0.7x
P/S Ratio-1.0x
P/E RatioIs TGK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TGK income statement (TTM) | |
|---|---|
| Revenue | US$13.26m |
| Cost of Revenue | US$8.66m |
| Gross Profit | US$4.60m |
| Other Expenses | US$13.67m |
| Earnings | -US$9.07m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.39 |
| Gross Margin | 34.72% |
| Net Profit Margin | -68.39% |
| Debt/Equity Ratio | 3.4% |
How did TGK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/19 16:31 |
| End of Day Share Price | 2023/09/21 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Precipio, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Jason McCarthy | Maxim Group |